Form 8-K - Current report:
SEC Accession No. 0001641172-25-011973
Filing Date
2025-05-22
Accepted
2025-05-22 06:45:22
Documents
16
Period of Report
2025-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45039
2 EX-5.1 ex5-1.htm EX-5.1 20056
3 EX-10.1 ex10-1.htm EX-10.1 240653
4 EX-99.1 ex99-1.htm EX-99.1 14167
5 GRAPHIC ex5-1_001.jpg GRAPHIC 8961
  Complete submission text file 0001641172-25-011973.txt   564035

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrxs-20250520.xsd EX-101.SCH 3014
7 XBRL LABEL FILE nrxs-20250520_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE nrxs-20250520_pre.xml EX-101.PRE 22358
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3786
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 25974703
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)